[Clinical and treatment characteristics of strongyloidiasis depending on the ABO(H) system of patient blood groups].
D000017:ABO Blood-Group System; D000328:Adult; D000871:Anthelmintics / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011208:Powders; D012426:Russia; D013322:Strongyloidiasis / Q000097:blood* / Q000175:diagnosis / Q000188:drug therapy; D013827:Thiabendazole / Q000008:administration & dosage; D013997:Time Factors
D000017:ABO Blood-Group System; D000871:Anthelmintics; D011208:Powders; D013827:Thiabendazole
Osobennosti kliniki i lecheniia strongiloidoza v zavisimosti ot gruppovoĭ prinadlezhnosti krovi bol'nykh po sisteme ABO(H).